Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers
Benjamin S. Abella, Eliana L. Jolkovsky, Barbara Biney, et al.
JAMA Internal Medicine (2020) Vol. 181, Iss. 2, pp. 195-195
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

COVID-19: breaking down a global health crisis
Saad I. Mallah, Omar Ghorab, Sabrina Al-Salmi, et al.
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 305
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
Larissa E. van Eijk, Mathijs Binkhorst, Arno R. Bourgonje, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 307-331
Open Access | Times Cited: 122
A living WHO guideline on drugs to prevent covid-19
François Lamontagne, Miriam Stegemann, Arnav Agarwal, et al.
BMJ (2021), pp. n526-n526
Open Access | Times Cited: 118
Prophylaxis against covid-19: living systematic review and network meta-analysis
Jessica Bartoszko, Reed Siemieniuk, Elena Kum, et al.
BMJ (2021), pp. n949-n949
Open Access | Times Cited: 103
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Charan Thej Reddy Vegivinti, Kirk W. Evanson, Hannah Lyons, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 93
Therapy for Early COVID-19
Peter Kim, Sarah W. Read, Anthony S. Fauci
JAMA (2020) Vol. 324, Iss. 21, pp. 2149-2149
Closed Access | Times Cited: 127
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham, Ananta Bangdiwala, Melanie R. Nicol, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 11, pp. e835-e843
Open Access | Times Cited: 125
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Ruanne V. Barnabas, Elizabeth R. Brown, Anna Bershteyn, et al.
Annals of Internal Medicine (2020) Vol. 174, Iss. 3, pp. 344-352
Open Access | Times Cited: 91
COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
Ruth Fernandez‐Ruiz, Jacqueline L Paredes, Timothy B. Niewold
Translational research (2020) Vol. 232, pp. 13-36
Open Access | Times Cited: 88
Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial
Raymond C.S. Seet, Amy M.L. Quek, Delicia Shu Qin Ooi, et al.
International Journal of Infectious Diseases (2021) Vol. 106, pp. 314-322
Open Access | Times Cited: 88
Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned
Akrithi Udupa, David Leverenz, Stephen J. Balevic, et al.
Current Allergy and Asthma Reports (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Autophagy in health and disease: From molecular mechanisms to therapeutic target
Guang Lu, Yu Wang, Yin Shi, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 62
Hydroxychloroquine in the prevention of COVID-19 mortality
April Jorge
The Lancet Rheumatology (2020) Vol. 3, Iss. 1, pp. e2-e3
Open Access | Times Cited: 63
Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions
Ying Han, Kai Yuan, Zhe Wang, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 51
The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials
Kimberley Lewis, Dipayan Chaudhuri, Fayez Alshamsi, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0244778-e0244778
Open Access | Times Cited: 50
Adjunctive Nutraceutical Therapies for COVID-19
Lalita Subedi, Stephanie Tchen, Bhakta Prasad Gaire, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1963-1963
Open Access | Times Cited: 45
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
Paulo Ricardo Martins‐Filho, Lis Campos Ferreira, Luana Heimfarth, et al.
The Lancet Regional Health - Americas (2021) Vol. 2, pp. 100062-100062
Open Access | Times Cited: 45
Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis
Saad Alhumaid, Ali A. Rabaan, Kuldeep Dhama, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1289-1289
Open Access | Times Cited: 31
Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
Xabier García‐Albéniz, Julia del Amo, Rosa Polo, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 8, pp. 789-796
Open Access | Times Cited: 28
Risk factors and frequency of COVID-19 among healthcare workers at a tertiary care centre in India: a case–control study
Nishanth Dev, Ramesh Chand Meena, Devendra Gupta, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 5, pp. 551-556
Open Access | Times Cited: 36
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)
Susanna Naggie, Aaron P. Milstone, Mario Castro, et al.
International Journal of Infectious Diseases (2023) Vol. 129, pp. 40-48
Open Access | Times Cited: 12
Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons
Nils Rother, Cansu Yanginlar, Rik G.H. Lindeboom, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 9, pp. 100146-100146
Open Access | Times Cited: 36
Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules
Kenana Al Adem, Aya Shanti, Cesare Stefanini, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 447-447
Open Access | Times Cited: 32
The time to offer treatments for COVID-19
Binh Ngo, Paul E. Marik, Pierre Kory, et al.
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 5, pp. 505-518
Open Access | Times Cited: 31
The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
Alessio Danilo Inchingolo, Gianna Dipalma, Angelo Michele Inchingolo, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 881-881
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top